Literature DB >> 1419635

The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region.

D Serraino1, G Salamina, S Franceschi, D Dubois, C La Vecchia, J B Brunet, R A Ancelle-Park.   

Abstract

This paper describes the epidemiology of AIDS-associated non-Hodgkin's lymphoma (NHL) in the World Health Organization (WHO) European Region. Data, collected by the WHO Collaborating Centre on AIDS in Paris, France, were derived from the national AIDS surveillance systems of 21 countries. Among 53,042 cases reported as of the end of June 1991, 1,617 (3.0%) had NHL as the presenting clinical manifestation of AIDS. The proportion of cases presenting with NHL ranged from 1.1% in children infected perinatally to 3.9% among haemophiliacs. In comparison with intravenous drug users (IVDUs) (2.6% of whom had NHL), a moderate excess was found among homosexual or bisexual men (odds ratio - OR -:1.2, 95% confidence interval - CI -:1.0-1.3). Over time, the proportion of NHL was constant, but whereas among homosexual or bisexual men the frequency of NHL as AIDS-indicator disease significantly increased (9.7% per year), among IVDUs a significant downward trend emerged (17.1% per year). In respect to age, two peaks of NHL were seen at the age groups 10-19 (3.8%) and 50-59 (4.3%). The proportion of AIDS-associated NHL significantly increased with increasing age among homosexual and bisexual men and heterosexuals whereas it decreased among IVDUs. All these differences, however, have to be interpreted cautiously on account of the limitations of the reporting systems.

Entities:  

Mesh:

Year:  1992        PMID: 1419635      PMCID: PMC1977999          DOI: 10.1038/bjc.1992.384

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  AIDS-related lymphoid neoplasia. The Memorial Hospital experience.

Authors:  D A Lowenthal; D J Straus; S W Campbell; J W Gold; B D Clarkson; B Koziner
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

2.  AIDS-associated non-Hodgkin's lymphoma in Italy: intravenous drug users versus homosexual men. The Italian Cooperative Group on AIDS-Related Tumors (GICAT).

Authors:  S Monfardini; E Vaccher; R Foà; U Tirelli
Journal:  Ann Oncol       Date:  1990       Impact factor: 32.976

Review 3.  Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas.

Authors:  J E Karp; S Broder
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

Review 4.  The occurrence of malignant tumors in immunosuppressed states.

Authors:  I Penn
Journal:  Prog Allergy       Date:  1986

5.  Epstein-Barr virus in AIDS-related primary central nervous system lymphoma.

Authors:  E M MacMahon; J D Glass; S D Hayward; R B Mann; P S Becker; P Charache; J C McArthur; R F Ambinder
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

6.  AIDS-associated non-Hodgkin lymphoma.

Authors:  V Beral; T Peterman; R Berkelman; H Jaffe
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

7.  Cancer in the European Community and its member states.

Authors:  O M Jensen; J Estève; H Møller; H Renard
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

8.  Immunosurveillance and cancer: epidemiologic observations.

Authors:  J F Fraumeni; R Hoover
Journal:  Natl Cancer Inst Monogr       Date:  1977-12

9.  Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries.

Authors:  J Casabona; M Melbye; R J Biggar
Journal:  Int J Cancer       Date:  1991-01-02       Impact factor: 7.396

10.  Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy.

Authors:  J M Pluda; R Yarchoan; E S Jaffe; I M Feuerstein; D Solomon; S M Steinberg; K M Wyvill; A Raubitschek; D Katz; S Broder
Journal:  Ann Intern Med       Date:  1990-08-15       Impact factor: 25.391

View more
  6 in total

1.  Molecular determinants of the human antibody response to HIV-1: implications for disease control.

Authors:  M Viau; M Zouali
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

Review 2.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

Review 4.  A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.

Authors:  G Nasti; D Errante; S Santarossa; E Vaccher; U Tirelli
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

5.  Current Management of AIDS Related Non Hodgkin's Lymphoma.

Authors:  Kathryn Fife; Mark Bower
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 6.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.